Special educators' knowledge regarding psychotropic interventions for students with emotional and behavioral disorders

Remedial and Special Education

Volumn 29, Issue 5, 2008, Pages 269-279

  Ryan, Joseph B ^a   Reid, Robert ^b   Ellis, Cynthia ^c  

^a CLEMSON UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Emotional and behavioral disorders; Psychotropic medications; Special educators

Indexed keywords

EID: 51649118872     PISSN: 07419325     EISSN: None     Source Type: Journal    
DOI: 10.1177/0741932507313015     Document Type: Article

References (40)

1. American Academy of Child and Adolescent Psychiatry. (2001). Prescribing psychoactive medications for children and adolescents. Washington, DC: Author.
2. Andrews, G. (1991). Anxiety, personality, and anxiety disorders. International Review of Psychiatry, 25 (4). 453-459.
3. Barkley, R.A. (1991). Introduction to the special issue: Child psychopharmacology. Journal of Clinical Child Psychology, 20 (3). 226-231.
4. Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577-585.
5. Connor, D.F., Boone, R.T., Steingard, R.J., Lopez, I.D., & Melloni, R.H. (2003). Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11, 157-168.
6. Connor, D.F., Ozbayrak, K.R., Harrison, R.J., & Melloni, R.H. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8 (1). 27-38.
7. Copeland, E.D. (1991). Medications for attention disorders and related medical problems. Atlanta, GA: SPI Press.
8. Dillman, D.A. (2000). Mail and internet surveys (2 nd ed.). New York: John Wiley.
9. Dulcan, M.K. (2007). Helping parents, youth, and teachers understand medications for behavioral and emotional problems (3 rd ed.). Washington, DC: American Psychiatric Press.
10. Epstein, M.H., Singh, N.N., Luebke, J., & Stout, C.E. (1991). Psychopharmacological intervention. II: Teacher perceptions of psychotropic medication for students with learning disabilities. Journal of Learning Disabilities, 24 (8). 477-483.
11. FDA Public Health Advisory. (2003). Reports of suicidality in pediatric patients being treated with antidepressant medications for major depressive disorder (MDD). Retrieved February 1, 2004, from http://www.fda.gov/cder/drug/ advisory/mdd.htm
12. Forness, S.R., & Kavale, K.A. (1988). Psychopharmacologic treatment: A note on classroom effects. Journal of Learning Disabilities, 21 (3). 144-147.
13. Forness, S.R., & Kavale, K.A. (2001). Ignoring the odds: Hazards of not adding the new medical model to special education decisions. Behavioral Disorders, 26 (4). 269-281.
14. Forness, S.R., Kavale, K.A., & Davanzo, P.A. (2002). The new medical model: Interdisciplinary treatment and the limits of behavior-ism. Behavioral Disorders, 27 (2). 168-178.
15. Forness, S.R., Kavale, K.A., Sweeney, D.P., & Crenshaw, T.M. (1999). The future of research and practice in behavioral disorders: Psychopharmacology and its school implications. Behavioral Disorders, 24 (4). 305-317.
16. Gadow, K.D. (1982). School involvement in pharmacotherapy for behavior disorders. The Journal of Special Education, 16 (4). 385-399.
17. Halfors, D., & Fallon, T. (1998). An examination of psychotropic drug treatment for children with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 6, 56-66.
18. Konopasek, D.E. (2005). Medication fact sheets: A behavioral medication reference guide for the educational professional. Boston: Sopris West Educational Services.
19. Lohrmann-O'Rourke, S., & Zirkel, P.A. (1998). The case law on aversive interventions for students with disabilities, Exceptional Children, 65 (1). 101-123.
20. Mattison, R.E. (1999). Use of psychotropic medications in special education students with serious emotional disturbance. Journal of Child and Adolescent Psychopharmacology, 9 (3). 149-155.
21. Mayo Clinic. (n.d.). Drugs and supplements. Available at http://www.mayoclinic.com/health/drug-information/DrugHerbIndex
22. McCarthy, A.M., Kelly, M.W., & Reed, D. (2000). Medication administration practices of school nurses. Journal of School Health, 70 (9). 371-376.
23. MTA Cooperative Group. (2004). National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113, 754-761.
24. Murray, J.N. (1976). Is there a role for the teacher in the use of medication for hyperkinetics ? Journal of Learning Disabilities, 9, 30-35.
25. Oswald, D.P. (2002). The new medical model and beyond: A response to Forness and Kavale. Behavioral Disorders, 27, 155-157.
26. Pappadopulos, E., MacIntyre, J.C., Crimson, M.L., Findling, R.L., Malone, R.P., Derivan, A., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 42 (2). 145-161.
27. Runnheim, V.A., Frankenberger, W.R., & Hazelkorn, M.N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorders, 21 (4). 306-314.
28. Ryan, J.B., Reid, R., Gallagher, K., & Ellis, C. (in press). Prevalence rates of psychotropic medications for students placed in residential care. Behavioral Disorders.
29. Ryan, J.B., & Peterson, R.L. (2004). Physical restraints in schools. Behavioral Disorders, 29 (2). 157-183.
30. Safer, D.J., & Malever, M. (2000). Stimulant treatment in Maryland Public Schools. Pediatrics, 106 (3). 533-539.
31. Schur, S.B., Sikich, L., Findling, R.L., Malone, R.P., Crimson, M.L., Derivan, A., et al. (2003). Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 132-143.
32. Singh, N.N., Epstein, M.H., Luebke, J., & Singh, Y.N. (1990). Psychopharmacological intervention. I: Teacher perceptions of psychotropic medication for students with serious emotional disturbance. The Journal of Special Education, 24 (3). 283-295.
33. Snider, V.E., Busch, T., & Arrowood, L. (2003). Teacher knowledge of stimulant medication and ADHD. Remedial and Special Education, 24, 46-56.
34. Sweeney, D.P., & Forness, S.R. (1997). An update on psychopharmacologic medication: What teachers, clinicians, and parents need to know. Intervention in School & Clinic, 33 (1). 4-22.
35. Sweeney, D.P., Forness, S.R. & Levitt, J.G. (1998). An overview of medications commonly used to treat behavioral disorders associated with autism, Tourette syndrome, and pervasive developmental disorders. Focus on Autism and Other Developmental Disabilities, 13, 144-150.
36. Thompson PDR. (2003). Monthly Prescribing Reference, 19, 106.
37. U.S. Department of Education. (2004). Twenty-sixth annual report to Congress on the implementation of the Individuals With Disabilities Education Act. Washington, DC: Author.
38. Weithorn, C.J., & Ross, R. (1975). Who monitors medication ? Journal of Learning Disabilities, 8, 59-62.
39. Wood, F.H. (2001). Looking back-Looking ahead: Programs for students with emotional and behavioral problems at the millennium. Preventing School Failure, 45 (2). 52-58.
40. Zito, J.M., & Safer, D.J. (2005). Recent child pharmacoepidemiological findings. Journal of Child and Adolescent Psychopharmacology, 15 (1). 5-9.